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ARTICLE
Structure of Csx1-cOA4 complex reveals the basis
of RNA decay in Type III-B CRISPR-Cas
Rafael Molina 1,6, Stefano Stella 1,6, Mingxia Feng2,3,6, Nicholas Sofos1, Vykintas Jauniskis1,
Irina Pozdnyakova4, Blanca López-Méndez4, Qunxin She2,3,5 & Guillermo Montoya 1,4
Type III CRISPR-Cas multisubunit complexes cleave ssRNA and ssDNA. These activities
promote the generation of cyclic oligoadenylate (cOA), which activates associated CRISPR-
Cas RNases from the Csm/Csx families, triggering a massive RNA decay to provide immunity
from genetic invaders. Here we present the structure of Sulfolobus islandicus (Sis) Csx1-cOA4
complex revealing the allosteric activation of its RNase activity. SisCsx1 is a hexamer built by
a trimer of dimers. Each dimer forms a cOA4 binding site and a ssRNA catalytic pocket. cOA4
undergoes a conformational change upon binding in the second messenger binding site
activating ssRNA degradation in the catalytic pockets. Activation is transmitted in an allos-
teric manner through an intermediate HTH domain, which joins the cOA4 and catalytic sites.
The RNase functions in a sequential cooperative fashion, hydrolyzing phosphodiester bonds
in 5′-C-C-3′. The degradation of cOA4 by Ring nucleases deactivates SisCsx1, suggesting that
this enzyme could be employed in biotechnological applications.
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CRISPR-Cas systems provide adaptive immunity to bacteriaand most archaea against mobile genetic elements such asinvading plasmids and viruses, via an interference
mechanism1–4. They rely on CRISPR arrays, which are short
repetitive DNA segments interspersed with unique spacer
sequences generated during encounters with invading nucleic
acids; hence, constituting a genetic record of previous infections.
Type III systems incorporate the cas10 gene5, which codes for a
multidomain protein6. This system is further divided into at least
four subtypes: III-A, III-B, III-C, and III-D. Among them, several
III-A and III-B systems have been characterized. Subtype III-A
modules contain four additional proteins (Csm2–Csm5) and
target plasmid DNA in vivo3. Subtype III-B modules contain ﬁve
or six additional proteins, Cmr1 and Cmr3-Cmr7, and four of
them (Cmr1, Cmr3, Cmr4, and Cmr6) are RNA-binding proteins.
These systems cleave RNA in vitro7,8, and in contrast with all
other characterized CRISPR-Cas systems, the Csm and Cmr
systems are unique among CRISPR-Cas effectors in that they
mediate both RNA and DNA interference9,10, the latter of which
is transcription-dependent11. In addition, csm6/csx1-like gene
family encode poorly characterized RNases frequently associated
with Type III CRISPR-Cas systems5,12. The Csm6/Csx1 RNases
are thought to non-speciﬁcally degrade foreign transcripts and
play auxiliary or sometimes essential functions during Type III
interference even though they are not part of the effector
complex11,13–15. Csm6 genes are preferentially associated to type
III-A, while Csx1 is found in types III-B, III-C, and III-D with no
clear link to a particular subtype5,16. Recently, it has been shown
that the Cas10 subunit of the Csm and Cmr complexes synthe-
sizes cyclic oligoadenylates (cOAs), which act as second mes-
sengers to allosterically regulate the Cas-associated ribonucleases
Csm617,18 and Csx119,20, triggering robust interference in the
presence of an invader. Although the structures of Csx1 from P.
furiosus (Pfu)21 and S. solfataricus (Sso) (PDB:2I71), and Csm6
from T. thermophilus (Tt)14 and T. onnurineus (To)22 have been
determined, the heterogeneity of the abundant Type III CRISPR-
Cas systems5,16, the presence of Ring nucleases23 and divergences
in the protein sequences suggest different regulatory mechanisms
(Supplementary Fig. 1, Supplementary Data 1). Recently it has
been found that ToCsm6 autoregulates its activity by cleaving
cOA4 in its CARF domain22; however, no information is available
for the Csx1 RNase family. To address that in the current study,
we solved the atomic structures of SisCsx1 in its apo and cOA4
(cOA composed of 4 AMP units) bound forms. We show that
cOA4 binding activates a cooperative sequential catalytic response
in a hexameric SisCsx1 complex and that the RNase activity is
switched-off by Ring nucleases, which cleave cOA423. Further, a
structure-function analysis revealed that the activation by the
cyclic molecule triggers speciﬁc cleavage of phosphodiester bonds
between cytidines.
Results
SisCsx1 is a hexameric RNase. SisCsx1, as other members of the
Csm6/Csx1 family5,12, is composed of an N-terminal CRISPR-
Cas-associated Rossmann Fold (CARF) domain connected to an
α-helical higher eukaryotes and prokaryotes nucleotide-binding
(HEPN) domain by a helix-turn-helix (HTH) domain (Fig. 1a).
We expressed SisCsx1 in S. islandicus, and the protein was pur-
iﬁed as previously described24. A SEC-MALLS analysis revealed
that SisCsx1 is an oligomer of 300 kDa corresponding to a hex-
americ assembly (Supplementary Fig. 2). A cryoEM map of the
complex at medium resolution (Fig. 1b, Supplementary Fig. 3,
Supplementary Table 1) was used as a model to solve the phase
problem by molecular replacement in an apo SisCsx1 crystal
belonging to the P21 space group (Methods). The Cα backbone
built in this map was later combined with an iodine derivative of
a better diffracting crystal of SisCsx1 in the space group I212121 to
determine the structure of the apo SisCsx1 to 2.9 Å. Subsequently
the apo SisCsx1 structure was used two determine by molecular
replacement two SisCsx1 conformations in complex with cOA4 at
3.1 and 2.7 Å resolution respectively (Supplementary Table 2,
Methods), thus providing the molecular details of the RNase
activation by the secondary messenger.
The SisCsx1 monomers are curled around the two-fold axis to
form a dimer (Fig. 1c), and three of these dimers oligomerize
through their HEPN domains into an equilateral trimer, thus
assembling into a hexamer (Fig. 1b). Each dimer contains a cOA4
binding site at the vertex of the triangular assembly (Fig. 1d), and
a catalytic pocket located 70 Å away inside the triangular
oligomer along the two-fold dimer axis (Fig. 1e). The two-fold
axis bisects the cOA4 and catalytic pockets in the dimer. Hence,
the triangular assembly forms two equilateral triangles, one inside
the other, with the vertexes formed by the CARF and HEPN
domains, building the cOA4 binding and catalytic sites in each
dimer (Fig. 1b, c).
Despite the conservation of the domain architecture between
Csm6 and Csx1 RNases, a comparison of SisCsx1 with ToCsm6,
TtCsm6, PfuCsx1 and SsoCsx1 reveals large differences in protein
sequence (Supplementary Fig. 1) and topology, especially in the
HTH and HEPN domains (Fig. 2a, b). Only the CARF domain
displays structural conservation between these proteins. These
differences determine that in SisCsx1, the monomers are curled
around the dimer axis (Fig. 1c, Fig. 2b), while the dimers of the
other Csx1 and Csm6 RNases interact along the axis from the
CARF to the HEPN domains (Fig. 2b). In addition, the sequence
alignment and the superposition reveal a unique insertion region
in the HEPN domain of SisCsx1, which is the responsible for the
protein hexamerization (Supplementary Fig. 1, Fig. 2a, b).
Collectively, these observations suggest that while cOA4 binding
is conserved, the mode of RNase regulation may be different.
SisCsx1-cOA4 complex displays different conformations. The
SisCsx1-cOA4 complex structure provides evidence of how the
cOA4 activator binding to the CARF domain triggers RNA
degradation. We synthesized cOA4 using puriﬁed Type III-B
SisCmr−α complex (Supplementary Fig. 4), and observed that the
binding of cOA4 at room temperature, barely activates SisCsx1,
while heating the reaction mixture triggered full RNase activity
(Supplementary Fig. 5a). As with other HEPN domain nucleases,
SisCsx1 does not require metal cofactors for its activity (Sup-
plementary Fig. 5b). To explore these differences, we crystallized
the SisCsx1-cOA4 complex by soaking the compound in crystals
of the apo SisCsx1 at 25 °C, and we also co-crystallized the
complex after heating up the mixture of cOA4 with the isolated
SisCsx1 to monitor possible conformational changes that could
elicit the RNase activity by the presence of cOA4. The different
crystallization procedures yielded the same type of crystals
(Supplementary Table 2), which displayed two different con-
formations of cOA4 (conf1 and conf2) in the binding pocket,
along with rearrangements of the protein moiety (Fig. 3, Sup-
plementary Fig. 6, Supplementary movie 1, 2).
The dimeric assembly of SisCsx1 is essential for the formation
of the cOA4 binding and catalytic pockets by the CARF and
HEPN domains. The curled arrangement of the monomers
positions the CARF domain of one monomer on top of the HTH
domain of the other, while the regions spanning residues 405–427
in the HEPN domains form two “pins” that clip each monomer
between the HTH and the HEPN domains (Fig. 1c–e, Fig. 2b).
The cOA4 binding cleft is formed by the loops connecting several
secondary structure elements of the CARF domains, including
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residues in loops spanning residues 6–18, 28–30, 47–54, 92–100,
153–158 and 178–188. The conformational changes upon cOA4
binding induce a reshaping of the loops, so that the oval cleft
observed in the apo structure shifts to form a cruciform pocket, in
which the cOA4 is bound (Fig. 3, Supplementary movie 1). This
reconﬁguration of the cOA4 binding pocket promotes a change in
the electrostatic potential of the cavity turning the neutral
potential observed in the apo structure to the polar cleft observed
in conf1 and conf2 (Supplementary Fig. 7A).
A conf1-conf2 transition triggers RNase activity. Each Csx1
monomer hosts a pair of adenines of cOA4, A1-A2 and A3-A4
(Fig. 3). A comparison of the cOA4 conformations in conf1 and
conf2 revealed that the molecule undergoes a conformational
change in the binding pockets of the hexamer (Fig. 3,
Supplementary movie 1). In the conf1 conﬁguration, cOA4 dis-
plays a “wrinkled” conformation of the cyclic compound with all
bases in a syn or near to syn arrangement in two of the second
messenger binding pockets (Fig. 3a, Supplementary Fig. 6). The
A1 base makes polar interactions with the main chain of S51 and
A1 ribose 2-OH interacts with the main chain of D10. A2 is
stabilized in the syn conﬁguration by polar contacts with the main
chains of S15 and F29. All contacts in the A3, A4 pair are made
by residues in the second monomer where these nucleotides are
located. The A3 base is stabilized in a near syn conﬁguration by
interactions with the side chain of S51′ as well as with the main
chains of S51′ and S98′ while A3 ribose 2-OH contacts with the
side chain of Y14′. A3 phosphate interacts with G182. The A4
phosphate contacts the G156′ amide thanks to N158, which
arranges the loop by contacting with the main chain of T154′ and
G156′ to promote that interaction. Finally, the A4 base is
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Fig. 1 Structure of SisCsx1 endoribonuclease. a Domain organization of SisCsx1. b Cartoon model of the apo SisCsx1 crystal structure superimposed on
the cryoEM map used to solve the phase problem. Each monomer is colored differently. Asterisks indicate the cOA4 binding sites and the black circles the
catalytic pockets. c The monomers of SisCsx1 are twisted around the dimer axis. Detailed view of one of the dimers with the different domains showing
the cOA4-binding and catalytic pockets. The monomers are shown following the color scheme in panel a. A pale tone of the same color is used to
differentiate each monomer. d Top view of the cOA4-binding pocket between the CARF domains colored in magenta. (e) Bottom view of the SisCsx1 dimer
showing the RNase catalytic site built by the HEPN domains (colored in blue)
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stabilized in the syn conﬁguration by polar contacts with the side
chain of Y19′ and the main chain of S15′ and F29′. Interestingly,
A4 phosphate is stabilized by contacting with the side chains of
N158 and N158′ through a water molecule. Multiple polar and
hydrophobic contacts with the main and side chains of several
residues in the cleft contribute to accommodate the cOA4
molecule. However, in the third binding site, cOA4 displays an
alternate conﬁguration syn and anti, due to a conformational
change to the anti conﬁguration in A2 and A4 by stabilizing their
contacts with Y19 and Y19′, respectively (Fig. 3a, b, Supple-
mentary Fig. 6).
The disposition of cOA4 in conf2 reveals a rearrangement of
the cyclic compound, whose conﬁguration coincides again in two
of the three binding pockets (Fig. 3c, d, Supplementary Fig. 6). An
inversion of the phosphate groups forces the P=O bonds of A1
and A3 towards the bottom of the pocket, inducing the changes
from syn to the anti conformation of the A2 and A4 nucleotides,
thus transiting from the “wrinkled” conformation observed in
conf1 to a more symmetrical arrangement in conf2. This change
in the phosphate backbone and base conﬁguration is supported
by the Fo-Fc omit maps of the cyclic compound and is
accompanied by new polar and hydrophobic interactions in the
binding site (Supplementary Fig. 7b-c, Supplementary movie 1).
The phosphate inversion in cOA4 is stabilized in both cases by
hydrogen bonds of the phosphate groups of A1 and A3 with
N158 and N158′ through a water molecule. A rotamer change of
H155 in both monomers allows the polar interaction of the
imidazole group with the A2 and A4 bases in each monomer,
thus positioning the cyclic compound into the cruciform pocket.
In addition, A2 and A4 phosphates are stabilized by the side
chains of Y14 and Y14′. Finally, the anti conformation of A2 and
A4 is stabilized by interactions of the base with the main chain of
S15, S15′, F29′, and V180′ and the OH of Y19′, while the syn
conﬁgurations observed for A1 and A3 are stabilized by polar
interactions with the main chain of D10, D10′, S51, S51′, and S98
and hydrophobic contacts with M181 side chain in both
monomers. The alternate conﬁguration observed in the third
binding pocket is accompanied by a reshaping of the polar and
hydrophobic interactions in the binding site (Fig. 3c, d, Fig. 4b–d,
Supplementary Fig. 6).
Comparison of cOA4 binding by ToCsm6 and SisCsx1. The
amino acids involved in the cOA4 binding are well-conserved
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Fig. 2 Comparison between type III CRISPR-associated ribonucleases. a Structural comparison between SisCsx1 and the dimeric SsoCsx1, PfuCsx1, ToCsm6,
TtCsm6. Ribbon representation of the SisCsx1 (green) and PfuCsx1, SsoCsx1 and TtCsm6 (orange) monomers which have been superposed using the DALI
server. SsoCsx1 (PDB 2I71) r.m.s.d. to SisCsx1 is 5.1 Å for 184 residues out of 376 with an identity of 20%, for PfuCsx1 (PDB 4EOG) r.m.s.d. to SisCsx1 is 6.1
Å for 200 residues out of the 466 of the protein with an identity of 12%, for ToCsm6 (PDB 6O6S) r.m.s.d. to SisCsx1 is 6.0 Å for 194 residues out of the
433 of the protein with an identity of 15%, while for TtCsm6 (PDB 5FSH) the r.m.s.d. is 5.0 Å for 224 out of the 448 of the protein with an identity of 11%.
b Comparison of the dimeric arrangements of SsoCsx1, PfuCsx1, ToCsm6, TtCsm6 with SisCsx1
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between the CARF domains of Csx1 and Csm6 ribonucleases.
These include SisCsx1 residues Y14, Y19, S51, T154, H155, G156,
N158, while the hydrophobic V180 and M181 could be sub-
stituted by other non-polar residues (Supplementary Fig. 1). A
recent analysis of the ToCsm6-cOA4 complex shows that upon
binding, the cyclic molecule is cleaved by the CARF domain, thus
deactivating its RNase activity22. However, W14 and H132, which
have been identiﬁed as important residues in the CARF domain
of ToCsm6 for cOA4 cleavage, are not well conserved among the
Csm6/Csx1 proteins. A genomic analysis of 294 prokaryotic
genomes shows that these two residues are present in less than
10% of the Csm6 proteins and they are frequently replaced by Y
and S respectively (Supplementary Data 1). In the case of the
Csx1 family only 5% of the proteins encode these residues in the
equivalent positions, the H residue is commonly found while W is
substituted by other amino acids, generally by Y, as observed in
SisCsx1 (Supplementary Fig. 1, Supplementary Data 1). A
superposition of the ToCsm6 and SisCsx1 structures shows that
the conformations of the CARF domain and the cyclic molecule
are different (Fig. 4a–d), specially because cOA4 is not cleaved in
the SisCsx1 structures (Fig. 3, Supplementary Fig. 7B-C). ToCsm6
cOA4 degradation involves W14, H132 and N135 residues, cor-
responding to Y14, H155 and N158 in SisCsx1 (Fig. 4a–d),
consequently, the key W14 is substituted by Y14 in SisCsx1
altering the possible catalytic conﬁguration. In addition, the
conﬁguration of N135 side chain, which has been linked to the
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cleavage of cOA422, can be found pointing inwards (non-cleaved
cOA4) or outwards (cleaved cOA4) of the cyclic oligoadenylate
ring. In contrast, we observed that N158 in SisCsx1, is pointing
inwards in the apo, conf1 and conf2 structures (Fig. 4a–d).
Overall, these observations indicate that the CARF domain of
SisCsx1 cannot cleave cOA4.
SisCsx1 RNase activation by cOA4 is regulated by Ring
nucleases. To elucidate whether SisCsx1 can cleave cOA4, we
performed a cleavage assay of the cyclic molecule in the presence
and absence of Ring nucleases, which have been shown to
deactivate the cOA4 -stimulated RNAse activity of the Csx1
family members via degradation of the cyclic molecule23. We
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tested whether SisCsx1 could cleave cOA4 or whether its activa-
tion by cOA4 was affected by the presence of Ring nucleases
(Fig. 4e–g). No cleavage of the cyclic molecule by SisCsx1 could
be observed in the absence of Ring nucleases, as it was equally
observed for the dimeric SsoCsx123. However, a substantial
decrease of SisCsx1 RNase activity could be observed in the
presence of Ring nucleases, thereby endorsing the deactivating
effect caused by the action of these enzymes on the cyclic com-
pound23. Consequently, the lack of conservation of key amino
acids for catalysis (ToCsm6 W14 and H132) in the Csm6 family
and the absence of cOA4 cleavage in SisCsx1, suggest that dif-
ferent RNase regulatory mechanisms are employed by other
members of the Csm6/Csx1 families.
SisCsx1 activation by cOA4 displays cooperativity. SisCsx1
binding of cOA4 is cooperative with a Hill coefﬁcient n, of 2 and a
Kd of ~18 nM (Supplementary Fig. 8A). Single mutants in the
CARF domain such as N158A, H155 A and S51A are still able to
display detectable RNase activity and a double mutation H155D/
N158D is needed to abrogate RNase activity (Supplementary
Fig. 8B). The shape of the pocket and the conformational change
upon second messenger binding is reminiscent of a “tippy tippy
tap” paper toy, i.e., the conﬁguration of the binding pocket is
coupled with conformational changes in the cOA4 molecule to
accommodate the compound. Collectively, these ﬁndings indicate
that the conﬁguration of cOA4 undergoes conformational chan-
ges between conf1 and conf2, which are transmitted to the HTH
domain for RNase activation (Supplementary movie 2).
The structure of SisCsx1 and cOA4 binding data strongly
suggested that the endoribonuclease activation by the cyclic
compound is cooperative. The SisCsx1 hexamer is built because
of a split helical insertion (V365-N400) and the last helix at the
C-terminus (D445-A454) in the HEPN domain (Fig. 5, Supple-
mentary Fig. 1). The α-helix spanning residues 375-391,
establishes a series of contacts with the same segment in the
adjacent monomer with the helices inversely oriented (Fig. 5a),
and a well-conserved cysteine bridge (C361-C380) positions the
hexamerization helix. The helices ﬁt into each other and the
central interaction surface is mainly hydrophobic. The hydro-
phobic interface is ﬂanked by several polar interactions (Fig. 5b).
To understand how catalysis works upon cOA4 binding, we
performed activity experiments, which demonstrated that SisCsx1
displays cooperative catalysis (Fig. 5c, Supplementary Fig. 8d).
The cleavage of a ssRNA substrate was quantiﬁed in the presence
of increasing amounts of cOA4. The sigmoidal curve displayed a
Hill coefﬁcient n, of 2.5, indicating a cOA4 dependent
cooperativity to catalyze phosphodiester hydrolysis of the ssRNA
substrate. The hydrogen bond pattern of the interaction surfaces
between the HEPN domains of the hexamer is different in the
apo, conf1 and conf2 structures (Fig. 5d), revealing that cOA4
binding induces a remodeling of the interactions in the catalytic
domains. While the central hydrophobic interfaces are very
similar in the three conformations, an interchangeability of the
hydrogen bonding scheme of R391, Y387, K446, A453 and K364
could be observed between the apo, conf1 and conf2 structures
(Fig. 5d, Supplementary Table 3, Supplementary movie 3). These
interactions occurring at the C-terminus of each monomer
appear to provide a signaling pathway within the HEPN domains
of the hexamer.
Interestingly, this region is in the neighborhood of the pin
extension from another monomer, which ﬁts snugly between the
HEPN and HTH domains, providing a staggered interaction of
the catalytic sites in the hexamer (Fig. 1e). This arrangement of
the hexamer provides the scaffolding supporting a sequential
cooperativity mechanism transmitting the cOA4 binding signal
from the CARF through the HTH (Supplementary movie 2)
domains to the catalytic sites in the different HEPN domains
(Supplementary movie 4) through the hexamer oligomerization
interface (Supplementary movie 3). To test this observation, we
designed the I383A/L390D/R391A mutant, which disrupts key
interactions for oligomerization in the helical insertion (residues
375-391) without compromising dimer assembly (Supplementary
Fig. 2). The I383A/L390D/R391A mutant displayed cOA4 binding
(Supplementary Fig. 8a); however, its RNase activity is severely
affected indicating that the hexamer is essential for ssRNA decay
(Supplementary Fig. 8c).
The high RNase activity (Supplementary Fig. 5a) and the
changes observed in the HEPN interfaces, suggest that upon
cOA4 binding, the change of conformation between conf1 and
conf2 (Fig. 2) would be coupled with the full activation of the
RNase activity by signaling the conformational change through
the HTH and the HEPN pins (Supplementary movie 4), thus
remodeling the contacts between the HEPN hexamer interfaces
(Fig. 5, Supplementary movie 3). Collectively, the analysis
indicates that the interplay of the interactions in the HEPN
domain interfaces is a consequence of the intramolecular
signaling of cOA4 binding, which is propagated through the
hexamer to induce RNase activity in the catalytic sites.
SisCsx1 catalytic center. The active center cleft comprises R354,
D372, R389, R399, N400, M403, H404, T409, and D410 residues
(Supplementary Fig. 1, Fig. 6a, b). The SisCsx1 dimeric
arrangement results in a symmetric placement of these amino
acids, creating a diagonal electropositive stripe ﬂanked by two
electronegative regions on each side (Fig. 6a). Changes in the
interfaces of HEPN domains observed in the apo, conf1, and
conf2 structures induce subtle conformational differences in the
side chains of these residues (Supplementary movie 5). In fact,
these rearrangements appear to be responsible for the RNase
activation. We attempted to co-crystallize SisCsx1 with an excess
of cOA4 or ssRNA, but we were unable to visualize the cyclic
compound or the oligonucleotide in the active site in the HEPN
domain. However, we observed two additional densities from
sulfate ions present in the crystallization solution associated with
R354 and R354′ in the catalytic pocket (Supplementary Fig. 9A).
This ﬁnding, together with our mutational analysis (Supple-
mentary Fig. 8C) and the electrostatic potential of the catalytic
site, offered some hints on orientation of the ssRNA phosphate
Fig. 4 Comparison of SisCsx1:cOA4 and ToCsm6:cOA4 CARF domains and RNase deactivation. Detailed view superimposition at the CARF domains of
SiScsx1:cOA4 complex in Conf1 asterisk (a) or Conf1 solid circle (b) vs. ToCsm6:cOA4. Detailed view superimposition at the CARF domains of SiScsx1:
cOA4 complex in Conf2 solid square (c) or Conformation 2 solid triangle (d) vs. ToCsm6:cOA4. S. islandicus Ring nucleases 0455 (e) and 0811 (f)
deactivate the RNase activity of SisCsx1. Increasing concentrations of both Ring nucleases from 10 nM to 150 nM were incubated with 25 nM of cOA4 at
70 °C for 30min followed by addition of 18 nM of SisCsx1 and 2.5 μΜ of RNA1 and further incubation at 70 °C for 5 min. The reactions were then separated
using 15% Novex TBE-urea gel (Invitrogen). g Cleavage of cOA4 by Ring nucleases 0455 and 0811. On the left side of the gel cOA4 is incubated with Ring
nucleases 0455 and 0811. The cyclic compound migrates faster than the linear product generated by the ring nucleases. On the right side of the gel SisCsx1
has been included in the reaction showing that it does not cleave cOA4 and protects its degradation by the ring nucleases. Each experiment for the e, f, g
panels has been repeated at least three times. The error bars represent the s.d. Source data are provided as a Source Data ﬁle for 4E-G
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backbone in the active center. To understand the mechanism of
phosphodiester hydrolysis, we utilized the identiﬁed key residues
in an information-driven ﬂexible docking modeling approach25,26
of a polyC oligonucleotide in the catalytic pocket (Fig. 6a). As
expected, the docking results revealed a ssRNA backbone located
on the diagonal electropositive stripe, with R354, R399, R389,
N400 in possible contact distances of the phosphate groups
(Fig. 6a, b). In the model, the bases of the ssRNA can interact
with the electronegative patches in the upper left and lower right
corners of the catalytic cleft where T385, D410, S408, T409, and
D372 are located (Fig. 6a, b). The position of the phosphate
backbone places one of the phosphodiester bonds between the
H404 and H404′ in the center of the cavity, suggesting that these
residues are directly involved in catalysis. This conclusion is
supported by the observation that the H404A mutation abolishes
cleavage (Supplementary Fig. 8C) and the abrogation of SisCsx1
activity at high pH (Supplementary Fig. 5C). Histidine is a residue
conducive for phosphodiester catalysis as it can accept and donate
protons since the pKa value of histidine is close to neutral.
Because of the dual role of histidine in catalysis and depending on
whether the ssRNA enters the symmetric catalytic site with a 5′-3′
or 3′-5′ polarity, one of the H404 residues would be positioned to
activate the 2′-OH of the ribose, thus initiating the cleavage
reaction. The transition state could be stabilized by R399 or N400,
which are positioned in the vicinity of the H404.
Some similitudes between SisCsx1 and another RNases with
histidines in their catalytic centers can be found. An example is
the dimeric RNase L, an interferon activated RNase, which
contains two histidines in the active center. However, phospho-
diester catalysis by RNase L supposedly involves only one of
them27. In SisCsx1, the two histidines are close and the
movements of the HEPN domains observed in the different
structures do not suggest large rearrangements in the active site
after cOA4 binding (Supplementary movie 5) as observed in
RNase L, suggesting that both histidines are involved in catalysis.
The proposed mechanism more closely resembles that of RNase
A, a classical ssRNA endonuclease, which also contains two
histidines in the catalytic site but lacks the two-fold symmetry
observed in the SisCsx1 dimer. These histidines alternate their
role as proton donor and acceptor during catalysis28. Although,
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further analysis will be needed to fully decipher SisCsx1 ssRNA
phosphodiester hydrolysis, the current evidence suggests that
SisCsx1 catalytic center would allow phosphodiester hydrolysis
independently of the ssRNA substrate polarity in the pocket.
SisCsx1 cleaves phosphodiester bonds between cytidines. Some
endoribonucleases can catalyze reactions involving RNA mole-
cules containing speciﬁc sequences, structures or sequences
within a speciﬁc structure providing tools for RNA manipulation.
However, a possible SisCsx1 cleavage speciﬁcity was ambiguous24.
In contrast with previous suppositions, we observed that SisCsx1
exhibits a strong preference for cleaving substrates with phos-
phodiester bonds between 5′-C–C-3′, and with a minor and very
low efﬁciency ones with phosphodiester bonds between 5′-U-C-3′
and 5′-U-A-3′ (Fig. 6c). Such cleavage preference likely arises
from the putative contacts between the cytosine base and the
acidic regions of the pocket (Fig. 6a, b). Further activity experi-
ments with different ssRNA substrates revealed that the cleavage
occurs in the central part of the oligonucleotide, with the efﬁ-
ciency of the otherwise preferential 5′-C–C-3′ cleavage greatly
diminished when the phosphodiester bond between cytidines is
located at the 5′- or 3′-end of the substrate molecule (Fig. 6c).
The cleavage assay also reveals that the ssRNA must be at least
12nt long to observe cleavage. As the distance between the cat-
alytic centres is around 35 Å, a ssRNA substrate between 10-12
nucleotides could interact with two catalytic sites, suggesting that
they may work on the same RNA molecule simultaneously, which
would agree with the observed cooperativity. Based on the data
presented in this manuscript, we propose a sequential coopera-
tivity model for SisCsx1 RNase. In this model, cOA4 binding
subsequently signals to the monomers in the other two dimers of
the hexamer to facilitate binding of other cOA4 molecules pro-
moting full activation of the RNase activity (Fig. 7).
Discussion
In this study, we present mechanistic evidence regarding
SisCsx1 ssRNA cleavage activation by cOA4, thereby showing the
molecular basis of how this second messenger acts on members of
the Csx RNase family to trigger a massive RNA decay. Our work
shows that the SisCsx1 oligomer displays positive sequential
cooperativity to hydrolyze phosphodiester bonds after binding
cOA4, following the Koshland, Némethy and Filmer (KNF) model
(Fig. 7). The binding of the cyclic oligoadenylate promotes the
conformational switch on the other subunits by decreasing the
energy making the conformational change thermodynamically
favourable; hence, facilitating that the rest of the SisCsx1
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molecules undergo the conformational change allowing binding.
Our work shows that full SisCsx1 activation is achieved after a
transition of cOA4 conﬁguration upon binding, thus triggering a
large ssRNA decay to stop infections. Although, we could not
unveil the reason of the strong preference displayed by SisCsx1 to
cut C–C phosphodiesters in ssRNA, we speculate that this clea-
vage preference could be related to their abundance in sequences
that infect this type of bacteria or in mRNAs that could code for
proteins that avoid the cell to enter quiescence.
There are obvious differences between the activation
mechanism of ToCsm6 and SisCsx1. To rationalise the distinct
type III RNase regulation by cOA4, we performed a genomic
analysis using a large number of prokaryotic genomes (Supple-
mentary Data 1). Our study shows that Csm6 (Type III-A) pro-
teins seem to be preferentially dimers, as a BLAST search found
no Csm6 containing the SisCsx1 insertion region in their HEPN
domain. In addition, only few Csm6 genes display the residues
(W14 and H132) involved in cOA4 cleavage by the CARF domain
of ToCsm6, suggesting that the majority of Csm6 proteins may
not cleave cOA4 to autoregulate their activity. An example is
TtCsm6 where these residues are substituted by Y and S
respectively (Supplementary Fig. 1, Supplementary Data 1),
indicating that cleavage of cOA4 by the CARF domain of the
RNase may not be a general mechanism in the Csm6 family.
Among the genomes containing Csx1 (III-B, III-C, and III-D),
species belonging to the Sulfolobus, Sulfurisphaera, Acidianus and
Metallosphaera geni, display the oligomerization insertion, and
therefore are most likely hexamers, while the rest lack this
sequence and seem to be dimers. Almost all Csx1 proteins,
including both dimers and hexamers, do not contain the W14
and H132 residue combination involved in cleavage of the cOA4
by the CARF domain of ToCsm6. In addition, it has been shown
that SsoCsx1 (dimer) does not cleave cOA423, similarly to SisCsx1
(hexamer) (Fig. 4g). Both species contain Ring nuclease genes,
suggesting that organisms encoding both Csx1 and Ring
nucleases do not seem to cleave cyclic oligoadenylates using the
CARF domain of the RNase, but rather use the Ring nucleases to
deactivate Csx1 RNase activity. Collectively, our analysis indicates
that the differences observed between both Csm6 and Csx1
RNases and their regulatory mechanisms, represent the large
diversity of strategies developed during evolution to adapt the
heterogeneous CRISPR-Cas Type III systems to the habitats of
these organisms. Given the large number of prokaryotes con-
taining Type III systems new regulatory mechanisms could be
found in future studies.
CRISPR-Cas systems have often been considered as a prokar-
yotic immune system that ﬁght viruses and other mobile genetic
elements. An analysis of how the Type III CRISPR-Cas systems
address viral infection, in conjunction with the presented
mechanistic analysis of SisCsx1 ssRNA degradation, is strikingly
reminiscent of the 2,5-oligoadenylate synthetase (OAS)/RNase L
system, one of the principal IFN antiviral pathways29, which
involves the activation of RNase L, an ubiquitous cellular
endoribonuclease27. Although there are obvious differences with
the Type III CRISPR-Cas, the general architecture of the defense
response exhibits a similar mechanistic organization: after an
initial step during which the viral genetic material is sensed as an
invader (by Type III Csm/Cmr complexes), a second messenger
molecule is produced (cOA) to activate an oligomeric RNase
(Csm6/Csx1), which (at least in the case of Csx1) speciﬁcally
cleaves ssRNAs in the cell. Collectively, all these resemblances
suggest that CRISPR-Cas Type III systems may be prokaryotic
Fig. 7Model for SisCsx1 RNase catalysis activation by cOA4. The binding of
cOA4 (tetralobal shape) by the CARF domains fully activates the ﬁrst dimer
(strong blue and strong sky blue) and induces a conformational change
through the HTH to the HEPN domains of two adjacent monomers (light
blue and light sky blue) favoring cOA4 binding in any of their available
cOA4 binding sites. The binding of the second cOA4 molecule fully
activates the second dimer (strong blue and strong sky blue), promoting
some initial RNase activity and triggering conformational changes in the
two monomers of the third dimer (light blue and light sky blue) leading to
the binding of the third cOA4 molecule and the full RNase activation
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ancestors of the more elaborated innate immunity pathways in
eukaryotic systems.
The activation of the SisCsx1 RNase catalytic activity in the
presence of cOA4, together with the speciﬁc cleavage between
cytidine sequences and the possibility to inhibit ssRNA decay
using Ring nucleases (Fig. 4e, f), suggest that SisCsx1 could be
employed as a modular switch in synthetic biology applications,
thus controlling gene expression by regulating mRNA decay.
Further, the RNase activity could be used in nucleic acid detec-
tion, as in the recently developed SHERLOCK system as its
“cousin” Csm630.
Methods
Strains and growth conditions. Sulfolobus islandicus strains employed in this
work included the genetic hosts E233S1 (ΔpyrEFΔlacS), E233 (ΔpyrEF)31 and
Δcsx1Δα, a csx1 deletion strain lacking the cmr-α gene cassette derived from E233
(Supplementary Table 4). The strains were grown in SCV medium (0.2% sucrose,
0.2% Casamino acids, 1% vitamin solution, and basic salts) at 78 °C. If required,
uracil was supplemented to 20 μg/ml. Transformation of Sulfolobus cells was
performed by electroporation as previously described32.
Construction of S. islandicus Δcsx1Δα. The Δcsx1Δα mutant was constructed
using the CRISPR-based genome-editing method33. A protospacer was identiﬁed in
the csx1 gene with which two oligonucleotides were designed (csx1spacerI–F and
csx1spacerI-R) and annealing of the two oligonucleotides gave the spacer fragment,
which was cloned into pSe-RP9, giving pAC-csx1-S1. Homologous arm of the csx1
deletant allele was generated by SOE-PCR using csx1-F-SalI, csx1-SOE-R, csx1-
SOE-F, and csx1-R-NotI. Insertion of the homologous arm into pAC-csx1-S1
yielded pGE-csx1 (Supplementary Tables 4–5-6). The plasmid was introduced into
Δα, a cmr-α deletant strain derived from E23311 by transformation, giving Δcsx1Δα.
The genotype of the mutant was conﬁrmed by PCR ampliﬁcation of the deletant
allele of csx1 and sequencing of the resulting PCR fragment. PCR was conducted
using Phanta Max Super Fidelity DNA polymerase (Vazyme).
Construction of expression plasmids. Six new substitutions were designed for the
S. islandicus Csx1, namely H404A, S51A, N158A, I383A/L390D/R391A, H155A
and H155D/N158D (Supplementary Table 6). The Csx1 expression plasmid of
Csx1, pSe-Csx124, was employed as the template to generate the designed sub-
stitutions using In-Fusion® HD cloning kit (Takara Bio USA, Inc), and the
mutagenesis was conducted using the primers listed in Supplementary Table 6,
following the instruction of the manufacturer. All primers (Supplementary Table 6)
were synthesized by the Integrated DNA Technology (IDT, USA). The sequences
of the wild-type csx1 gene and the designed mutations were veriﬁed by DNA
sequencing of the constructed expression plasmids at MacroGen Europe
(Amsterdam, Netherlands). Sequences encoding for the Ring-0455 and Ring-0811
were synthesized by IDT. The genes were then cloned by In-Fusion HD Cloning
Plus (Tanaka) into pET-21.
Puriﬁcation of Csx1 and its protein variants from S. islandicus. His-tagged Csx1
and its mutated derivatives were over-expressed in, and puriﬁed from, S. islandicus
cells as previously described24. Each expression plasmid was used to transform
strain Δcsx1Δα. The resultant transformants were grown in SCV medium at 78 °C
until A600= 0.6–0.8. Then, 50 ml of the culture was transferred to 1 l of a pre-
warmed ACV medium (similar to SCV medium but with 0.1% arabinose instead of
0.2% sucrose) to induce the production of the Csx1 protein or its variants. When
the cell density was reached A600= 0.8, the cells were harvested by centrifugation.
The cell pellet was re-suspended in buffer A (20 mM HEPES pH 7.5, 30 mM
imidazole, and 500 mM NaCl). Cell envelope was disrupted by using French press.
After removing cell debris by centrifugation (10,000 × g, 30 min at 4 °C), the
resulting cell extract was loaded on a 1 ml HisTrap HP column (GE Healthcare).
After washing with 30 ml of Buffer A, the His-tagged protein was puriﬁed by
elution with a linear gradient of imidazole (30–500 mM), which was generated by
mixing Buffer A and Buffer B (20 mM HEPES pH 7.5, 500 mM imidazole, and
500 mM NaCl). The elution fractions containing Csx1 proteins were pooled,
concentrated and further puriﬁed by size exclusion chromatography (SEC) in
Buffer C (20 mM Tris-HCl pH 8.0, and 300 mM NaCl) using a Superdex 200
Hiload column (GE Healthcare). The quality of Csx1 proteins was evaluated by
SDS-PAGE. The Csx1-containing fractions were pooled together and stored at 4 °C
for further study.
Puriﬁcation of Ring nucleases. Proteins puriﬁcations of pET21-Ring-0455 and
pET21-Ring-0811 were expressed and puriﬁed from E. coli BL21 star (DE3) cells.
Cells were grown in LB media containing 50 µg/ml-1 ampicillin at 37 °C until and
OD 600 of 0.8 and the expression was induced by adding1 mM of isopropyl β-D-1-
thiogalactopyranoside (IPTG) at 16 °C overnight. The cells were harvested and re-
suspended in lysis buffer [50 mM HEPES pH 7.5, 500 mM NaCl, 10 mM Imidazole,
1 mM MgSO4, 0.5 mM TCEP, Benzonase]. Cells were lysed by sonication for
10 min with 10 s on and 10 s off cycle. Cell debris and insoluble particles were
removed by centrifugation. The supernatant was loaded onto a 5 ml Crude HisTrap
column (GE Healthcare) equilibrated in buffer A (50 mM HEPES pH 7.5, 500 mM
NaCl, 10 mM Imidazole, 0.5 mM TCEP). The elution was performed by a step
gradient of buffer B (buffer A plus 1 M imidazole). Enriched protein fractions and
applied onto a 5 ml HiTrap Heparin HP column (GE Healthcare) equilibrated with
buffer A2 (50 mM HEPES pH 7.5, 100 mM NaCl, 0.5 mM TCEP). The protein was
eluted with a linear gradient of 0–100% buffer B2 (50 mM HEPES pH 7.5, 2 M
NaCl, 0.5 mM TCEP). Protein-rich fractions were loaded onto a HiLoad 16/60 75
Superdex column (GE Healthcare) equilibrated in buffer G (50 mM HEPES pH 7.5,
100 mM NaCl, 0.5 mM TCEP). The protein peaks were concentrated (using 10 kDa
MWCO Centriprep Amicon Ultra devices), ﬂash-frozen in liquid nitrogen and
stored at −80 °C.
Synthesis of cyclic oligoadenylates (cOAs) by Cmr-α-RNP. Synthesis of cyclic
oligoadenylates (cOAs) by the Cmr-α-RNP from S. islandicus Rey15A was per-
formed as described19. Brieﬂy, a reaction mixture containing 20 mM MES pH 6.0,
5 mM MnCl2, 5 mM DTT, 100 μM ATP, 40 nM Cmr-α-RNP, and 200 nM SS1-46
target RNA was incubated at 70 °C for 30 min. The reaction was stopped by chilling
on ice.
Analysis of cOA alpha–ATP reaction products by ESI-MS. Products of COA
alpha reaction with ATP were analyzed by electrospray ionization mass spectro-
metry (ESI-MS) coupled with liquid chromatography (LC). ESI-MS was performed
in a negative mode using MicrTOF QII mass spectrometer (Bruker) with on-line
Ultimate 3000 HPLC system (Dionex). Reaction products were separated on
Kinetex EVO analytical column (Kinetex 1.7 μM EVO C18 100 Å 100 × 2.1 mm,
Phenominex) by applying a linear gradient of ammonium acetate/acetonitrile, as
follows: 0–2 min, 0 B; 2–22 min, 0 to 20% B; 22–25 min, 20–50% B; 25–29 min,
50–100% B. Chromatographic separation was performed at 30 °C. The mobile
phase A was 5 mM ammonium acetate in water, with the pH adjusted with
NH4OH to pH= 7.0. The mobile phase B was neat acetonitrile. The ﬂow rate was
set at 0.3 ml/min. The ionization capillary voltage was set to 4500 V. The data were
acquired in a scan mode in the m/z range of 100 to 2000.
Reverse-phase puriﬁcation of cyclic oligonucleotides. Cyclic oligonucleotides
were puriﬁed from the cOA alpha–ATP reactions by reverse phase liquid chro-
matography (RP-LC) using a Luna Omega semi-preparative column (Luna Omega
5 μm Polar C18 100 Å 250 × 10.0 mm, Phenomenex). Reaction products were
separated by a linear gradient, with % B increased from 0 to 17 in 40 min at a ﬂow
rate 5 ml/min. The mobile phase A was 50 mM triethylamine acetate (TEAA) in
water, pH 7.0, and phase B was 50 mM TEAA in 80% acetonitrile. Chromato-
graphic separation was performed at room temperature. Fractions containing cOA-
ATP reaction products were concentrated using a vacuum concentrator and ana-
lyzed by ESI-MS.
In vitro RNA cleavage assay. The RNA cleavage assays were performed with
SisCsx1 or its variants (the amount of protein is indicated in each assay), 2.5 μM 5′
FAM-labeled RNA, and 100 nM cOA4 (unless otherwise indicated) in a reaction
buffer (20 mM MES pH 6.0, and 5 mM MnCl2). The reactions were incubated at
70 °C for the speciﬁed time periods and stopped by adding 2×stop buffer (8 M urea
and 100 mM EDTA at pH 8.0) and cooling on ice. Samples were loaded on a 15%
Novex TBE-urea polyacrylamide gel (Invitrogen) or a 20% denaturing gel, and
analyzed according to the manufacturer′s instructions. RNA cleavage products
were visualized using an Odyssey FC Imaging System (Li-Cor).
SEC-MALS analysis. SEC-MALS experiments were performed using a Dionex
(Thermo Scientiﬁc) HPLC system connected in-line to a UV detector (Thermo
Scientiﬁc Dionex Ultimate 3000, MWD-3000), a Wyatt Dawn8+Heleos 8-angle
light-scattering detector and a Wyatt Optilab T-rEX refractive index detector. SEC
was performed using a Superdex 200 Increase 10/300 GL column (GE Healthcare)
at room temperature in a buffer containing 20 mM Tris pH 8.0, and 300 mM NaCl.
For the analysis, 50 μl of Csx1, Csx1/cOA4, and Csx1-I383A/L390D/R391A were
injected at 1.9 mg/ml, 0.4 mg/ml, and 1.9 mg/ml concentrations, respectively, and
0.5 ml/min ﬂow rate. ASTRA (version 6.1.17) software was used to collect the data
from the UV, refractive index, and light-scattering detectors. The weight average
molecular masses, Mw, were determined across the elution proﬁle from static LS
measurements using ASTRA software and a Zimm model, which relates the
amount of scattered light to the weight average molecular weight of the solute,
the concentration of the sample, and the square of the refractive index increment
(dn/dc) of the sample.
Binding assays. Preparation of the radioactively labelled cOA4 using 32P-α-ATP
was performed with extra supplementing 0.5 μl of 3000 Ci/mmol 32P-α-ATP
(PerkinElmer) in the reaction. The reaction was separated 24% of 19:1 acrylamide:
bis-acrylamide in TBE with 8M urea. The cOA4 was extracted from the gel by
overnight incubation of the gel slice in MilliQ water. The binding assay was
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performed by adding 2 μl 32P-labelled cOA4 to increasing amount of Csx1 or its
mutants from 1 to 120 nM in 20 mMMES pH 6. 0, 5 mM MnCl2 and incubating at
70 °C for 5 min, followed by analysis of 10% TBE gel (Invitrogen). The gel was
visualized by phosphor imaging.
Cooperativity and cleavage assay using dark-RNA. Dark-RNA (5′-UACUGGA
UG(Fluorescein-dT)CCCCUGAA(Dabcyl-dT)GUUGC-3′BHQ1) carrying an
internal ﬂuorescein ﬂuorophore (emission peak at 520 nm) and both an internal
(Dabcyl Quenching Range: 400–550 nm) and a 3′ (BHQ1 Quenching Range:
480–580 nm) quenching molecules was synthesized by Euroﬁns. Increasing con-
centration of cOA4 from 1 to 128 nM were incubated in the presence of 34 nM of
SisCsx1 and 0.2 μΜ dark-RNA at 70 °C for 3 min and the reactions were stopped
on ice. The ﬂuorescent released upon cleavage of the dark-RNA and the separation
between ﬂuorescein and the quenchers was measured using Varioskan™ (thermo-
ﬁsher) in the rage between 480 nm and 580 nm. The data points were analysed
using a non-linear regression [Agonist] vs. response—Variable slope (four para-
meters) model from PRISM.
Protein sequence analysis. To identify the catalytically relevant positions in Csm6
proteins, sequences from Methanocaldococcus and Thermococcus geni were aligned
using Clustal Omega34. These sequences were used to build a proﬁle and align the
rest of Csm6 using MUSCLE35. To identify the hexamerization regions for both
protein families, sequences of Csx1 from Sulfolobus, Sulfurisphaera, Acidianus and
Metallosphaera geni were used as a proﬁle. The same proﬁle was used for cataly-
tically relevant position analysis in Csx1 family. Protein sequences used in the
analysis were added from the identiﬁed csx1 and csm6 genes by Makarova et al.36,
together with the latest crystallized protein sequences and homologues. The amino
acid frequencies in columns with aligned catalytically relevant residues were ana-
lyzed for both protein families with Unipro UGENE toolkit37. Identiﬁers for all the
sequences used can be found in Supplementary Data 1, together with short
summaries.
Ring nucleases inhibition assay. Increasing concentrations of both ring-nucleases
from 10 nM to 150 nM were incubated with 25 nM of cOA4 at 70 °C for 30 min
followed by addition of 18 nM of SisCsx1 and 2.5 μΜ of RNA1 and further
incubation at 70 °C for 5 min. The reactions were then separated using 15% Novex
TBE-urea gel (Invitrogen).
Cryo-EM sample preparation and data acquisition. SisCsx1 sample was diluted
to 0.5 mg/ml in a buffer containing 150 mM NaCl and 20 mM Tris-HCl pH 8.
Then, 3 μl of sample was applied onto UltrAuFoil 300 mesh R0.6/1.0 holey grids
(Quantifoil) glow-discharged for 30 s at 5 mA (Leica EM ACE200), and plunge-
frozen in liquid ethane, cooled with liquid nitrogen, using a Vitrobot Mark IV
robot (FEI, Thermo Fisher Scientiﬁc) with the following settings: blotting for 3 s,
100% humidity, and 4 °C. Cryo-EM data were collected using aTitan Krios G3
transmission electron microscope (FEI, Thermo Fisher Scientiﬁc) operating at
300 kV at liquid nitrogen temperature. Two datasets (dose-fractioned movies) were
acquired using a Falcon 3ED direct electron detector (FEI, Thermo Fisher Scien-
tiﬁc) in electron-counting mode, with a calibrated pixel size of 0.832 Å and
nominal defocus range of −2.1 to −3.0 μm: 808 micrographs with 55 frames and a
dose rate of 1.09 e–/Å2, and 1253 micrographs with 39 frames with a dose rate of
1.01 e–/Å2, respectively. EPU was used for automated data acquisition (FEI,
Thermo Fisher Scientiﬁc). Cryo-EM statistics for data collection and processing are
summarized in Supplementary Table 1.
Image processing. All single-particle analyses were performed using the cisTEM
software38. The micrographs were resampled to 1 Å/pixel, motion corrected by
Unblur39, and the contrast transfer function (CTF) was estimated by CTFFIND440.
The images were ﬁltered at the detected CTF ﬁt resolution (maximum 4 Å), and
92,000 particles were picked using the automated ab initio particle picking algo-
rithm implemented in cisTEM. Since a mixture of dimeric and hexameric SisCsx1
particles was captured in the micrographs, the particle radii were optimized indi-
vidually for the two oligomeric states in order to pick as many particles as possible.
The particles were extracted using a 400 Å box and sorted by two rounds of 2D
class averaging, resulting in 44k particles. An initial 3D model was generated using
the cisTEM ab initio 3D reconstruction algorithm, which was subsequently auto-
reﬁned as one class to an overall resolution of 3.59 Å based on the gold-standard
Fourier shell correlation (FSC) 0.143 cutoff criterion. The map was sharpened
using the Autosharpen Map tool in PHENIX41, with a negative B-factor of 65.2 Å2
applied. Directional FSC analysis was performed to obtain 3D FSCs and evaluate
directional resolution anisotropy42, and a local resolution estimation was obtained
with MonoRes43.
Crystallization. Initial crystallization screening using the Csx1 apo sample was
performed at 298 K using the sitting-drop vapor-diffusion method and testing a
collection of commercially available crystallization screens. The initial drops con-
sisted of 0.1 μL of protein solution (7.1 mg/ml in 20 mM Tris pH 8.0, and 500 mM
NaCl) and 0.1 μL well solution, and were equilibrated against 70 μL of well
solution. After 3 day of incubation, the extensive initial screening rendered plate-
like crystals under two different crystallization conditions. Habit I crystals were
grown in 8% PEG 8000 and 0.1 M Tris pH 8.5; habit II crystals were produced in
0.350 M NaCl, 25% PEG 1000, 10% glycerol, and 0.1 M Tricine pH 8.0. Following
these initial hits identiﬁcation, both crystal growths were scaled up and optimized
using a Dragonﬂy (TTP) screen optimizer. While crystallization condition II was
intrinsically cryoprotectant, habit I crystals were cryo-protected by adding 35% (v/
v) glycerol to the mother liquor before ﬂash-freezing in liquid nitrogen. Iodine-
modiﬁed crystals were obtained by soaking habit II Csx1 native crystals overnight
in a modiﬁed mother liquor obtained by exchanging NaCl with NaI (250 mM).
Csx1:cOA4 conformation 1 crystals were prepared by soaking at room temperature
habit II Csx1 apo crystals overnight in their mother liquor solution that included
0.1 mM of the puriﬁed ligand cOA4. To generate Csx1:cOA4 crystals in con-
formation 2, Csx1 and the cOA4 ligand (2:1 molar ratio) were incubated at 343 K
for 10 min before growing them in 0.05 M LiSO4, 0.1 M HEPES pH 6.5, 28% PEG
600, and 10% glycerol.
X-ray diffraction data collection. All data were collected from frozen crystals at
100 K with EIGER and PILATUS detectors at beamlines PXI and PXIII (SLS,
Villigen, Switzerland) and at BioMax (MAX-IV, Lund, Sweden). Data processing
and scaling were accomplished using XDS44 POINTLESS and AIMLESS45 as
implemented in autoPROC46. Statistics for the crystallographic data and structure
solution are summarized in Supplementary Table 2.
Crystal structure solution, model building, and reﬁnement. Despite
SisCsx1 shares a similar domain architecture with TtCsm6, SsoCsx1, or PfuCsx1,
these proteins are divergent enough to make molecular replacement unsuccessful.
In addition, good heavy atom derivatives were not obtained and selenomethionine
substitution of SisCsx1 did not result in good diffracting crystals. Consequently, to
solve the phase problem for the initial crystals belonging to P21 space group, we
used a medium resolution map of the SisCsx1 300 kDa complex obtained by cryo-
EM as a search model in Phaser47. Initial molecular replacement phases where
subsequently improved by solvent ﬂattening and NCS averaging. A Cα model of
SisCsx1 was built using Autobuild in Phenix41. This model was used in combi-
nation with SAD phasing from an iodine derivative in the I212121 space group in
the CRANK2 pipeline48. The ﬁnal model was fully traced in this map. The
information provided by the cryo-EM map was helpful to trace some ﬂexible loops
in the crystal structure. The SisCsx1:cOA4 complex structure was solved by
molecular replacement, as implemented in the program PHASER47 using SisCsx1
apo structure as the searching model. All the models were then initially subjected to
iterative cycles of model building and reﬁnement with Coot49, PHENIX41 and
REFMAC50. Final cycle reﬁnements were performed with BUSTER51 yielding the
reﬁnement and data collection statistics summarized in Supplementary Table 2.
The Apo, Conf1 and Conf2 ﬁnal models have a Rwork/Rfree of 20/24, 18/23 and 19/
22%, with 1.1, 1.2 and 0.7% of the residues in disallowed regions of the Rama-
chandran plot, respectively.
HADDOCK ssRNA docking in the SisCsx1 catalytic pocket. HADDOCK version
2.226 using CNS52 for structure calculations was used to dock 6-nucleotide ssRNA
in the catalytic pocket of the HEPN domain. The crystal structures of the apo,
conf1 and conf2 SisCsx1 were used to extract the initial coordinates of the protein
for the docking and to identify the residues deﬁning the catalytic pocket. Residues
with atoms with centers within 10 Å of H404 and with all-atom relative solvent
accessibility greater than 20% deﬁne the catalytic pocket. This comprises residues
348, 354, 370–373, 389–393, 399, 400–404, and 410–415 of each SisCsx1 monomer.
The linear molecule coordinates for the ssRNA docking were generated in coot49.
The default version topology and parameter ﬁles provided for proteins in HAD-
DOCK 2.2 were used to generate the protein and ligand structures. Brieﬂy, 1000
docked complex structures were generated in the ﬁrst rigid-body docking step (it0),
200 structures in the semi-ﬂexible simulated annealing (it1) and 200 structures
evaluated in the ﬁnal analysis. Two sets of distance restraints were used at different
stages of the docking protocol. For the rigid-body docking, it0, the entire binding
pocket and the ligand were deﬁned as active. For the ﬂexible reﬁnement steps, the
binding pocket was deﬁned as passive while the ligand was deﬁned as active.
Molecular dynamics simulations were switched off (the number of MD steps was
set to 0) for both rigid-body high temperature docking and the slow cooling
annealing step of the semi-ﬂexible simulated annealing. HADDOCK score was
used to rank the models. Models were clustered using the RMSD criteria with a 2.0
Å cutoff. The structures of the top clusters with lowest HADDOCK scores were
examined manually in PyMOL53.
Visualization. Figures were generated using PyMOL53, Chimera, and ChimeraX54.
Reporting summary. Further information on research design is available in
the Nature Research Reporting Summary linked to this article.
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Data availability
The EM map has been deposited in the EMDB under the code EMDB-4691. Atomic
coordinates and structure factors have been deposited in the Protein Data Bank under
the accession codes 6QZT [https://www.rcsb.org/structure/6QZT], 6R7B [https://www.
rcsb.org/structure/6R7B], and 6R9R [https://www.rcsb.org/structure/6R9R], accordingly.
The source data underlying Figs. 4e–g, Fig. 6c and Supplementary Figs. 5A–C, 8A–C are
provided as a Source Data ﬁle. The enquiry on genetic materials generated in this work
should be addressed to QS. All other data are available from the corresponding author
upon reasonable request.
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